Functional integration of a semi-synthetic azido-queuosine derivative into translation and a tRNA modification circuit

Substitution of the queuine nucleobase precursor preQ(1) by an azide-containing derivative (azido-propyl-preQ(1)) led to incorporation of this clickable chemical entity into tRNA via transglycosylation in vitro as well as in vivo in Escherichia coli, Schizosaccharomyces pombe and human cells. The resulting semi-synthetic RNA modification, here termed Q-L1, was present in tRNAs on actively translating ribosomes, indicating functional integration into aminoacylation and recruitment to the ribosome. The azide moiety of Q-L1 facilitates analytics via click conjugation of a fluorescent dye, or of biotin for affinity purification. Combining the latter with RNAseq showed that TGT maintained its native tRNA substrate specificity in S. pombe cells. The semi-synthetic tRNA modification Q-L1 was also functional in tRNA maturation, in effectively replacing the natural queuosine in its stimulation of further modification of tRNA(Asp) with 5-methylcytosine at position 38 by the tRNA methyltransferase Dnmt2 in S. pombe. This is the first demonstrated in vivo integration of a synthetic moiety into an RNA modification circuit, where one RNA modification stimulates another. In summary, the scarcity of queuosinylation sites in cellular RNA, makes our synthetic q/Q system a 'minimally invasive' system for placement of a non-natural, clickable nucleobase within the total cellular RNA.

Automated summary

This study successfully incorporated an azide-containing derivative into tRNA via transglycosylation, resulting in a semi-synthetic RNA modification called Q-L1. The incorporation of this clickable chemical entity was demonstrated in vitro and in vivo, indicating its functional integration into translation and recruitment to the ribosome. The Q-L1 modification facilitated analytics through click conjugation, and was shown to maintain tRNA substrate specificity and promote further modification in cellular systems. This study represents the first in vivo integration of a synthetic moiety into an RNA modification circuit.